A Study of AT-02 in Subjects With Systemic Amyloidosis.
Condition: Amyloidosis; Systemic Intervention: Drug: AT02 Sponsors: Attralus, Inc.; Novotech (Australia) Pty Limited Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials